Gianluca Perego

15PUBLICATIONS
4CO-AUTHORS
Regenerative medicine (incl. stem cells)Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)ChemotherapyClinical pharmacy and pharmacy practice
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jul 27, 2022
Stability of a standardized preparation of methotrexate, cytarabine, and methylprednisolone hemisuccinate for intrathecal use.

Gianluca Perego, Giorgia Longobardo, Lucia ViganĂ²

|Apr 20, 2022
Ribociclib in the Treatment of Hormone-Receptor Positive/HER2-Negative Advanced and Early Breast Cancer: Overview of Clinical Data and Patients Selection.

Maria Chiara Parati, Rebecca Pedersini, Gianluca Perego

|Nov 22, 2021
Neoadjuvant or adjuvant immunotherapy in bladder cancer: biological opportunity or clinical utility?

Fausto Petrelli, Gianluca Perego, Ivano Vavassori

|Feb 05, 2021
Is there any place for novel agents in treating biliary tract cancer?

Gianluca Perego, Valentina Burgio, Renata Nozza

|Aug 09, 2020
Treating metastatic clear-cell renal cell carcinoma: beyond immunotherapy.

Gianluca Perego, Paolo Barzaghi, Ivano Vavassori

|Jun 30, 2020
Continuous-infusion and outpatient setting: A chance for patients, a challenge for hospital pharmacists.

Gianluca Perego, Francesco Gregis, Laura Rossi

Pageof 3